Literature DB >> 1845970

A functional soluble extracellular region of the platelet-derived growth factor (PDGF) beta-receptor antagonizes PDGF-stimulated responses.

D S Duan1, M J Pazin, L J Fretto, L T Williams.   

Abstract

The platelet-derived growth factor beta-receptor (PDGFr) is a 180-kDa transmembrane glycoprotein which binds BB-PDGF with high affinity. We have expressed the extracellular region of the receptor in Chinese hamster ovary cells using an expression vector that carries a dihydrofolate reductase gene as an amplifiable marker. Upon amplification of the receptor cDNA sequences by methotrexate a 110-kDa soluble form of the receptor extracellular region (XR) was secreted at 12 mg/liter. The soluble XR protein fully retained the high affinity specific binding of the intact PDGFr for BB-PDGF (apparent dissociation constant, 0.4 nM). In the presence of ligand the soluble XR protein formed complexes that migrated on sodium dodecyl sulfate gels at the size expected for dimers of the protein. When added to fibroblast cultures the soluble XR protein blocked the ability of BB-PDGF to stimulate DNA synthesis but did not alter the mitogenic effect of AA-PDGF. The XR fragment also inhibited the binding of BB-PDGF to PDGFr and the activation of PDGFr tyrosine kinase by BB-PDGF. Thus, the soluble extracellular region protein of the PDGFr binds BB-PDGF with high affinity and functions as a specific antagonist of BB-PDGF actions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1845970

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  The pericyte microenvironment during vascular development.

Authors:  Laura B Payne; Huaning Zhao; Carissa C James; Jordan Darden; David McGuire; Sarah Taylor; James W Smyth; John C Chappell
Journal:  Microcirculation       Date:  2019-05-27       Impact factor: 2.628

2.  Expression of platelet-derived growth factor and its receptor in livers of patients with chronic liver disease.

Authors:  Y Ikura; H Morimoto; M Ogami; H Jomura; N Ikeoka; M Sakurai
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

3.  Excess vascular endothelial growth factor-A disrupts pericyte recruitment during blood vessel formation.

Authors:  Jordan Darden; Laura Beth Payne; Huaning Zhao; John C Chappell
Journal:  Angiogenesis       Date:  2018-09-20       Impact factor: 9.596

Review 4.  [Pathophysiologic significance of growth factors and new therapeutic concepts in cardiovascular disease].

Authors:  S Rosenkranz; M Böhm; A Kazlauskas
Journal:  Med Klin (Munich)       Date:  1999-09-15

5.  Therapeutic angiogenesis due to balanced single-vector delivery of VEGF and PDGF-BB.

Authors:  Andrea Banfi; Georges von Degenfeld; Roberto Gianni-Barrera; Silvia Reginato; Milton J Merchant; Donald M McDonald; Helen M Blau
Journal:  FASEB J       Date:  2012-03-05       Impact factor: 5.191

6.  Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.

Authors:  R L Kendall; K A Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

7.  SLR3: a modified receptor kinase gene that has been adapted to encode a putative secreted glycoprotein similar to the S locus glycoprotein.

Authors:  J M Cock; B Stanchev; V Delorme; R R Croy; C Dumas
Journal:  Mol Gen Genet       Date:  1995-07-28

Review 8.  Soluble receptors for cytokines and growth factors: generation and biological function.

Authors:  S Rose-John; P C Heinrich
Journal:  Biochem J       Date:  1994-06-01       Impact factor: 3.857

9.  An alternatively processed mRNA from the avian c-erbB gene encodes a soluble, truncated form of the receptor that can block ligand-dependent transformation.

Authors:  T W Flickinger; N J Maihle; H J Kung
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

10.  Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities.

Authors:  S Werner; D S Duan; C de Vries; K G Peters; D E Johnson; L T Williams
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.